Preimplantation genetic screening and testing
Preimplantation genetic testing for aneuploidy (PGT-A, PGS) detects chromosome copy number abnormalities of embryos and is an effective method for selecting the best embryos. It helps to achieve better pregnancy results by selecting embryos with normal chromosomes for transfer. The method is particularly beneficial for women over 35 years old and patients with recurrent miscarriages or several unsuccessful fertility treatments. In general, transferring embryos with normal chromosomes produces better treatment results regardless of the woman’s age.
Out of a young woman’s normal looking embryos, 40–50% may have an abnormal number of chromosomes in a cell, i.e. be aneuploid, while for women over 40 this figure may be as high as 75–90%. The majority of chromosomal abnormalities lead to arrested development of the embryo or an early miscarriage. However, variation between patients is high, and unsuccessful treatments are not necessarily a result of chromosomal problems.
Source: US CDC/SART (left), Harton et al. (2013) Fertility and Sterility 106:1695-703 (right)
PGT-A treatment involves taking a biopsy of 5–8 cells from five to six days old embryos, which are then frozen using the vitrification method. Embryos with normal chromosome result can be thawed and transferred into the uterus. PGT-A helps us to avoid unnecessary embryo transfers and allows at best up to 70% pregnancy rates.
In PGT-A treatments, embryos are cultured in the EmbryoScope®, an incubator with a monitoring device facilitating improved embryo selection. Ask us for more details about Ovumia’s PGT-A embryo selection.
Total price of PGT-A (biopsy, dispatch of samples, the PGT-A test and EmbryoScope® culturing) according to the number of embryos studied:
|Total price (€)||1380||1780||2180||2580||2980||3380||3630||3880|
Test results will be available 10–15 days after the samples have been sent to the test laboratory. PGT counseling given by a biologist 80 €.
In connection with the PGT-A, it is also possible to study the embryo’s mitochondrial DNA from the same sample without additional cost (Mitoscore). NGS-based embryonic testing reveals the DNA of the chromosomes, as well as the mitochondrial DNA copy number (mtDNA). Studies show that mtDNA content in the embryo’s total DNA copy number correlates negatively with embryo viability. This is where Mitoscore is useful in embryo assessment.
PhD, Fertilisation treatment biologist, researcher, PGT specialist
M.A., Senior Embryologist, Laboratory Development Director, PGT specialist
PhD, Senior Embryologist, Customer Director